Tracon Pharmaceuticals, Inc.·4

Apr 21, 8:37 PM ET

LARUE WILLIAM R 4

4 · Tracon Pharmaceuticals, Inc. · Filed Apr 21, 2023

Insider Transaction Report

Form 4
Period: 2023-04-19
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2023-04-19+18,00018,000 total
    Exercise: $1.82Exp: 2033-04-18Common Stock (18,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION